Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
Credit: CC0 Public Domain

A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

The study, which was supported by the National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, confirmed that a group of inflammatory proteins called 'IL-36' play a significant role in the development of psoriasis and can, in theory, be blocked without posing a risk to .

Psoriasis, which causes red, flaky, crusty patches of skin covered with silvery scales, affects more than 1.8 million in the UK alone. The findings of this study, although still at an early stage, open up the possibility for the development of new drugs to tackle this often debilitating condition.

Dr. Francesca Capon, who led the study at King's College London said: "There was already some evidence to suggest that IL-36 played a significant role in psoriasis. Having confirmed this was the case, the question for us was whether we could block this molecule without posing a risk to patients."

To tackle this problem, Dr. Capon and her team contacted the Born in Bradford (BiB) project, a large study led by Prof John Wright at Bradford Royal Infirmary which is tracking the health of over 13,500 local children and their parents.

"We know that genetic mutations are more common in communities where parental relatedness is widespread and we found 12 women in the BiB cohort who carried a defect that naturally blocked IL-36," said Dr. Capon. "After a series of tests carried out by Dr Satveer Mahil at St John's Institute of Dermatology, we determined that the lack of IL-36 activation had not had an adverse effect on their health which suggests it would be safe to block this molecule in patients with psoriasis."

Medical technology which would enable the blocking of IL-36 group of in patients with psoriasis is already widely available.

Helen McAteer, Chief Executive of the Psoriasis Association, which part-funded the study, said: "Research into psoriasis is enabling us to not only understand the condition better, but the treatments better".

"Current research is having a positive impact on clinical effectiveness, better understanding is providing better treatment outcomes, ultimately improving the lives of those affected by psoriasis."

The paper "An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a therapeutic target", was published today (11 October) in the journal Science Translational Medicine.

Explore further: Psoriasis and psychiatric illnesses—what are the links?

More information: S.K. Mahil el al., "An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target," Science Translational Medicine (2017). stm.sciencemag.org/lookup/doi/ … scitranslmed.aan2514

Related Stories

Psoriasis and psychiatric illnesses—what are the links?

August 11, 2017
A new review examines the potential link between psoriasis and mental health conditions.

Psoriasis may up risk of melanoma, hematologic cancer

March 28, 2017
(HealthDay)—Patients with psoriasis may have a higher risk of melanoma and hematologic cancers than the general population, according to a study published in the April issue of the Journal of the American Academy of Dermatology.

Severe psoriasis predominantly affects men

March 24, 2017
The fact that men are overrepresented in psoriasis registers and consume more psoriasis care have long led researchers to believe that the common skin disease disproportionally affects men. A unique study with 5,438 Swedish ...

Severity of psoriasis linked to increased risk of death

August 29, 2017
The more the surface area of the body is covered by psoriasis, the greater the risk of death for the patient suffering from the condition, according to a new analysis by researchers in the Perelman School of Medicine at the ...

Exploring high cholesterol's link with psoriasis

June 12, 2017
A new Northwestern Medicine study published in the Journal of Clinical Investigation has demonstrated how a specific class of immune cells represent a previously unknown link between high cholesterol and the development of ...

Psoriasis impacts QoL for parents of affected children

January 23, 2017
(HealthDay)—Childhood psoriasis impacts parents' quality of life in multiple domains, especially their emotional well-being, according to a study published in the February issue of the Journal of the American Academy of ...

Recommended for you

Lactic acid bacteria can protect against Influenza A virus, study finds

December 13, 2017
Lactic acid bacteria, commonly used as probiotics to improve digestive health, can offer protection against different subtypes of influenza A virus, resulting in reduced weight loss after virus infection and lower amounts ...

Lyme bacteria survive 28-day course of antibiotics months after infection

December 13, 2017
Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of two papers published in the peer-reviewed journals PLOS ONE and American Journal of Pathology, that seem to support ...

Aging impairs innate immune response to flu

December 13, 2017
Aging impairs the immune system's response to the flu virus in multiple ways, weakening resistance in older adults, according to a Yale study. The research reveals why older people are at increased risk of illness and death ...

Drug blocks Zika, other mosquito-borne viruses in cell cultures

December 12, 2017
If there was a Mafia crime family of the virus world, it might be flaviviruses.

Study seeks to aid diagnosis, management of catatonia

December 11, 2017
Catatonia, a syndrome of motor, emotional and behavioral abnormalities frequently characterized by muscular rigidity and a trance-like mental stupor and at times manifesting with great excitement or agitation, can occur during ...

New compound stops progressive kidney disease in its tracks

December 7, 2017
Progressive kidney diseases, whether caused by obesity, hypertension, diabetes, or rare genetic mutations, often have the same outcome: The cells responsible for filtering the blood are destroyed. Reporting today in Science, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.